Results
ADVERSE REACTIONS
A total of 710 patients were enrolled from January to November 2021, including 353 individuals in 3 L split dose PEG group and 357 individuals in 2 L PEG group. After enrollment, 8 and 7 individuals in the 3 L and 2 L group, respectively did not undergo colonoscopy at last. Moreover, 28 individuals in 3 L split dose PEG group, and 22 individuals in 2 L PEG group were lost to follow-up, which means we failed to ring them up. Thus, there was a lack of information about adverse reactions for those people (Fig. Study flowchart